Do viruses play a role in peri-implantitis? by Brown, Timothy et al.
                                                                    
University of Dundee
Do viruses play a role in peri-implantitis?
Brown, Timothy; Young, Lindsey; Lamont, Thomas J.
Published in:
Evidence-Based Dentistry
DOI:
10.1038/s41432-020-0072-z
Publication date:
2020
Document Version
Peer reviewed version
Link to publication in Discovery Research Portal
Citation for published version (APA):
Brown, T., Young, L., & Lamont, T. J. (2020). Do viruses play a role in peri-implantitis? Evidence-Based
Dentistry, 21(1), 8-9. https://doi.org/10.1038/s41432-020-0072-z
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 28. Apr. 2020
Critical Appraisal Commentary 
 
Title/Question 
Do viruses play a role in peri-implantitis? 
 
Authors 
Timothy Brown, DCT2 Aberdeen Dental Hospital, Aberdeen, UK 
Lindsey Young, DCT1 Aberdeen Dental Hospital, Aberdeen, UK  
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A Commentary on:  
Akram Z, Al-Aali KA, Alrabiah M, Alonaizan FA, Abduljabbar T, AlAhmari F, Javed F, Vohra 
F. Current weight of evidence of viruses associated with peri-implantitis and peri-implant 
health: A systematic review and meta-analysis. Rev Med Virol. 2019 May;29(3): e2042. doi: 
10.1002/rmv.2042. Epub 2019 Mar 22. PubMed PMID: 30901504. 
 
 
Data Sources 
A search of electronic databases (EMBASE, MEDLINE, Cochrane Oral Group Trials 
Register and the Cochrane Central Register of Controlled Trials) along with a manual search 
of various Science Citation Indexed Journals. 
 
Study Selection 
Four cross-sectional studies and one case-control study were included where percentage 
levels of Herpes Simplex Virus Type 1 (HSV1), Epstein-Barr Virus (EBV) and 
Cytomegalovirus (CMV) were sampled for in both peri-implantitis affected and healthy 
implant sites, with the latter used as the control. Studies were excluded that investigated any 
other infective agent, had fewer than ten participants, was performed in vitro or involved 
subjects with only periodontal disease. 
 
Data Extraction and Synthesis 
Data extraction followed the Preferred Reporting Items for Systematic Review and Meta-
analysis (PRISMA) guideline process. Two examiners used the Newcastle Ottawa Scale to 
determine overall study quality while the key information was extracted and tabulated for 
comparison. The data was analysed using Chi-Squared test and I2 test for heterogenicity 
with a random effects or fixed affect models applied as appropriate. Risk difference of 
outcomes was displayed via a forest plot with 95% confidence intervals. Funnel plots were 
generated to evaluate publication bias. 
 
Results 
All four cross-sectional studies found searched for EBV, while three also looked for CMV. 
The case-control study included investigated for HSV1 presence only. EBV presence in peri-
implantitis sites was found to be statistically significant in three of the four studies despite 
obvious heterogeneity. CMV presence at peri-implantitis sites was statistically significant in 
all relevant studies, but the data displayed notable heterogeneity so as to render it 
insignificant. HSV1 exhibited similar percentage frequency in both healthy and diseased 
implant sites. 
 
Conclusions 
Virus prevalence was found to be increased in patients with peri-implantitis when compared 
to healthy sites but this assertion must be treated with caution as the data supporting it is 
weak due to the limited number of studies involved and the significant inherent heterogeneity 
they displayed. 
 
 
Grade rating 
Very Low 
 
Commentary 
Prevalence studies estimate 10% of dental implants placed will develop peri-implantitis and 
with over 12 million implants placed annually worldwide, this represents a huge potential 
disease burden (1). Understanding the pathogenesis of any disease is vital to develop 
accurate diagnostic classifications and effective treatment strategies. Our understanding of 
the aetiology of periodontal disease and peri-implantitis has evolved significantly, moving 
from viewing plaque bacteria as the sole concern, to appreciating it is a complex multi-
factorial inflammatory interaction involving a wide range of genetically determined immune-
modifying factors, underlying systemic inflammatory disorders and systemic diseases (2). 
This evolution of our understanding is highlighted by the regular and significant changes to 
periodontal disease classification systems over the years (1986, 1989, 1993, 1999 and 
2017). 
 
It has been theorised that the role of Human Herpes Viruses (HHVs) in peri-implantitis is 
through stimulation of toll-like receptors expressed in susceptible periodontal tissue cells 
leading to up-regulation of genes expressing interferons and pro-inflammatory cytokines (3). 
This systematic review compared the prevalence at diseased and healthy implant sites of 
the three most commonly implicated HHVs- HSV1, EBV and CMV- as a means of assessing 
this premise. The study question was explicitly stated using the PECO model but we must 
highlight the risk of solely using correlation of presence of HHVs in disease sites to infer 
causality. The study design followed the PRISMA protocol resulting in only five studies from 
45 search returns included for final assessment, but limiting the search to only journals 
published in English may have meant relevant data was missed from other important 
research countries. A further quality critique using the Newcastle-Ottawa scale determined 
only two studies were of a high standard. 
 
The authors highlighted important shortcomings in the studies assessed. This included the 
use of the more inaccurate paper point sampling technique in two papers, the lack of 
reporting the pocket depth the samples were taken from and the significant publication bias 
observed from the funnel plots for the studies investigating EBV and CMV. 
 
The analysis determined the only statistically significant virus presence in a diseased versus 
healthy implant site with an acceptable confidence interval was with the EBV. From this, the 
authors cautiously concluded that there is a link between peri-implantitis and HHVs, however 
we must disagree that this can be asserted from data extracted from so few studies of 
acceptable quality and in defiance of the obvious heterogeneity of the data. Further primary 
research of a more academically rigorous standard needs to be performed before asserting 
with certainty that viruses play a role in peri-implantitis development. 
 
Practice point 
The evidence outlined above is insufficient to show a causal role of viruses in peri-
implantitis. The mainstay of periodontal treatment remains effective biofilm disruption. 
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